Previous Close | 33.60 |
Open | 29.72 |
Bid | 33.98 x 30000 |
Ask | 34.18 x 30000 |
Day's Range | 29.72 - 31.20 |
52 Week Range | 29.42 - 51.65 |
Volume | |
Avg. Volume | 1 |
Market Cap | 1.22B |
Beta (5Y Monthly) | 1.62 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -10.74 |
Earnings Date | Oct 30, 2024 - Nov 04, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 99.50 |
Investing.com -- Ingevity (NYSE:NGVT) Corporation saw its stock drop by more than 14% on Thursday following the sudden departure of its President and CEO, John Fortson.
NORTH CHARLESTON, S.C., October 03, 2024--Ingevity today announced that John Fortson has departed as president and CEO and from the board of directors of the company.
The Capa HS series is the latest example of NGVT's current innovation push, which is extending the performance boundaries of Caprolactone technology.